Acutus Medical, Inc. (AFIB)
NASDAQ: AFIB · IEX Real-Time Price · USD
0.175
+0.011 (6.99%)
At close: Apr 18, 2024, 4:00 PM
0.165
-0.009 (-5.39%)
Pre-market: Apr 19, 2024, 8:38 AM EDT

Acutus Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
7.163.0317.268.462.842.17
Revenue Growth (YoY)
136.36%-82.44%103.96%198.45%30.93%-
Cost of Revenue
10.34.9432.9315.899.247.51
Gross Profit
-3.14-1.91-15.66-7.43-6.41-5.34
Selling, General & Admin
14.0720.3263.5250.3626.8513.33
Research & Development
3.483.1236.6833.4538.0319.08
Other Operating Expenses
-9.08-67.44000.790
Operating Expenses
8.47-44.01100.2183.8165.6632.41
Operating Income
-11.6142.1-115.87-91.24-72.07-37.75
Interest Expense / Income
5.665.155.685.5122.275.23
Other Expense / Income
64.3476.55-3.865.222.74.93
Pretax Income
-81.6-39.6-117.68-101.96-97.04-47.91
Income Tax
0.060.0200.0200
Net Income
-81.66-39.62-117.68-101.98-97.04-47.91
Shares Outstanding (Basic)
2928291111
Shares Outstanding (Diluted)
-28291111
Shares Change
3.46%-1.16%151.19%1597.67%23.12%-
EPS (Basic)
-2.81-1.40-4.11-8.94-144.41-87.78
EPS (Diluted)
-2.81-1.40-4.11-8.94-144.41-87.78
Free Cash Flow
-63.34-89.15-109.66-96.39-59.38-35.82
Free Cash Flow Per Share
-2.16-3.15-3.83-8.45-88.37-65.63
Gross Margin
-43.79%-63.02%-90.73%-87.72%-225.92%-246.72%
Operating Margin
-161.99%1388.85%-671.19%-1077.93%-2541.22%-1742.89%
Profit Margin
-1139.91%-1307.03%-681.71%-1204.88%-3421.69%-2211.77%
Free Cash Flow Margin
-884.10%-2941.11%-635.20%-1138.87%-2093.83%-1653.65%
EBITDA
-75.07-33.24-105.12-92.55-71.6-40.56
EBITDA Margin
-1047.89%-1096.80%-608.91%-1093.43%-2524.82%-1872.35%
Depreciation & Amortization
0.871.216.893.93.172.12
EBIT
-75.95-34.45-112.01-96.45-74.77-42.68
EBIT Margin
-1060.09%-1136.65%-648.82%-1139.56%-2636.50%-1970.27%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).